1.37

5.52% -0.08

After Hours: 1.40 0.03 +2.19%

AIM ImmunoTech Inc (AIM)

Overview News Price History Discussions Forecast Stock Split

AIM ImmunoTech Inc stock is traded at $1.37, with a volume of 55,683. It is down -5.52% in the last 24 hours and down -13.29% over the past month. AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen, a drug of macromolecular ribonucleic acid molecule for the treatment of chronic fatigue syndrome. It is also developing Ampligen for the treatment of Hepatitis B and HIV, as well as patients with renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, urothelial, prostate, and pancreatic cancer. AIM ImmunoTech Inc. has agreements with UMN Pharma Inc., Japan National Institute of Infectious Diseases, and Shionogi & Co., Ltd. for the evaluation and discussion of business relationships concerning a COVID-19 therapeutic and vaccine. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.

Previous Close:

$1.45

Open:

$1.38

24h Volume:

55,683

Relative Volume:

0.56

Market Cap:

$3.91M

Revenue:

$202.00K

Net Income/Loss:

$-28.96M

P/E Ratio:

-2.2833

EPS:

-0.6

Net Cash Flow:

$-21.85M

1W Performance:

-0.72%

1M Performance:

-13.29%

6M Performance:

+1,344%

1Y Performance:

+543.19%

1-Day Range:

$1.34

$1.4299

1-Week Range:

$1.34

$1.65

52-Week Range:

$0.0633

$20.35

AIM ImmunoTech Inc Stock (AIM) Company Profile

Name

AIM ImmunoTech Inc

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

352 448 7797

Address

2117 SW Highway 484, Ocala, FL

Employee

Twitter

@AIMImmuno

Next Earnings Date

2024-12-15

Latest SEC Filings

AIM's Discussions on Twitter

Compare AIM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AIM AIM ImmunoTech Inc	1.37	4.14M	202.00K	-28.96M	-21.85M	-0.60
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

AIM ImmunoTech Inc Stock (AIM) Latest News

Dec 10, 2025

AIM ImmunoTech Announces Release of the Next CEO Corner Segment - Yahoo Finance

Dec 10, 2025

Dec 08, 2025

Ascendiant Capital Maintains AIM ImmunoTech (AIM) Buy Recommendation - Nasdaq

Dec 08, 2025

Ascendiant Capital lowers AIM ImmunoTech stock price target to $22 on valuation - Investing.com Nigeria

Dec 08, 2025

Ascendiant Capital lowers AIM ImmunoTech stock price target to $22 on valuation By Investing.com - Investing.com South Africa

Dec 08, 2025

AIM: Analyst Maintains 'Buy' Rating, Lowers Price Target | AIM S - GuruFocus

Dec 08, 2025

Dec 06, 2025

Would You Still Hold AIM ImmunoTech Stock If It Fell Another 30%? - Trefis

Dec 06, 2025

Dec 05, 2025

How AIM ImmunoTech Inc. stock compares with tech leadersEarnings Recap Summary & Growth-Oriented Investment Plans - Newser

Dec 05, 2025

Will AIM ImmunoTech Inc. stock benefit from Fed rate cutsMarket Trend Report & Free Technical Confirmation Trade Alerts - Newser

Dec 05, 2025

How AIM ImmunoTech Inc. stock reacts to new regulations2025 Top Gainers & Reliable Volume Spike Alerts - Newser

Dec 05, 2025

Dec 04, 2025

Will AIM ImmunoTech Inc. stock deliver compounding returnsJuly 2025 Earnings & Daily Risk Controlled Trade Plans - Newser

Dec 04, 2025

Can AIM ImmunoTech Inc. stock expand revenue streamsDollar Strength & Fast Moving Stock Trade Plans - Newser

Dec 04, 2025

AIM ImmunoTech (NYSEAMERICAN:AIM) Cut to Hold at Zacks Research - Defense World

Dec 04, 2025

Dec 02, 2025

Is AIM ImmunoTech Inc. (HXB) stock resilient in recession scenariosJuly 2025 Setups & Free Accurate Trade Setup Notifications - Newser

Dec 02, 2025

Why AIM ImmunoTech Inc. stock fits value portfoliosQuarterly Market Summary & Verified Momentum Watchlists - Newser

Dec 02, 2025

Can AIM ImmunoTech Inc. (HXB) stock sustain margin levels2025 Institutional Moves & Fast Exit and Entry Trade Guides - Newser

Dec 02, 2025

Is AIM ImmunoTech Inc. stock supported by strong fundamentals - Newser

Dec 02, 2025

Dec 01, 2025

AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series - The Manila Times

Dec 01, 2025

AIM ImmunoTech (NYSE American: AIM) to join Virtual Investor Closing Bell chat Dec. 4 - Stock Titan

Dec 01, 2025

Nov 27, 2025

An analyst sees good growth prospects for AIM ImmunoTech Inc (AIM) - setenews.com

Nov 27, 2025

Nov 21, 2025